Pancreatic Cancer - Pipeline Review, H1 2018

  • ID: 4583874
  • Report
  • 2509 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 3-V Biosciences Inc
  • Biomunex Pharmaceuticals
  • Faron Pharmaceuticals Oy
  • Ipsen SA
  • Noxxon Pharma AG
  • Selecta Biosciences Inc
  • MORE
Pancreatic Cancer - Pipeline Review, H1 2018

Summary:

This latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2018, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights:

This latest pipeline guide Pancreatic Cancer - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Pancreatic Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 19, 146, 138, 2, 11, 289, 35 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages comprises 18, 11, 2, 1, 48 and 7 molecules, respectively.

Pancreatic Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatic Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Pancreatic Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Pancreatic Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Pancreatic Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatic Cancer (Oncology)
Reasons to buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Pancreatic Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Pancreatic Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3-V Biosciences Inc
  • Biomunex Pharmaceuticals
  • Faron Pharmaceuticals Oy
  • Ipsen SA
  • Noxxon Pharma AG
  • Selecta Biosciences Inc
  • MORE
Introduction

Pancreatic Cancer - Overview

Pancreatic Cancer - Therapeutics Development

Pancreatic Cancer - Therapeutics Assessment

Pancreatic Cancer - Companies Involved in Therapeutics Development

Pancreatic Cancer - Drug Profiles

Pancreatic Cancer - Dormant Projects 2

Pancreatic Cancer - Discontinued Products 2

Pancreatic Cancer - Product Development Milestones 2

Appendix 2

List of Tables

Number of Products under Development for Pancreatic Cancer, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..3), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..4), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..5), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..6), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..7), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..8), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..9), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..10), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..11), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..12), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..13), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..14), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..15), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..16), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..17), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..18), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..19), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..20), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..21), H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..22), H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018 (Contd..1), H1 2018

Number of Products under Development by Universities/Institutes, H1 2018 (Contd..2), H1 2018

Products under Development by Companies, H1 2018

Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Products under Development by Companies, H1 2018 (Contd..3), H1 2018

Products under Development by Companies, H1 2018 (Contd..4), H1 2018

Products under Development by Companies, H1 2018 (Contd..5), H1 2018

Products under Development by Companies, H1 2018 (Contd..6), H1 2018

Products under Development by Companies, H1 2018 (Contd..7), H1 2018

Products under Development by Companies, H1 2018 (Contd..8), H1 2018

Products under Development by Companies, H1 2018 (Contd..9), H1 2018

Products under Development by Companies, H1 2018 (Contd..10), H1 2018

Products under Development by Companies, H1 2018 (Contd..11), H1 2018

Products under Development by Companies, H1 2018 (Contd..12), H1 2018

Products under Development by Companies, H1 2018 (Contd..13), H1 2018

Products under Development by Companies, H1 2018 (Contd..14), H1 2018

Products under Development by Companies, H1 2018 (Contd..15), H1 2018

Products under Development by Companies, H1 2018 (Contd..16), H1 2018

Products under Development by Companies, H1 2018 (Contd..17), H1 2018

Products under Development by Companies, H1 2018 (Contd..18), H1 2018

Products under Development by Companies, H1 2018 (Contd..19), H1 2018

Products under Development by Companies, H1 2018 (Contd..20), H1 2018

Products under Development by Companies, H1 2018 (Contd..21), H1 2018

Products under Development by Companies, H1 2018 (Contd..22), H1 2018

Products under Development by Companies, H1 2018 (Contd..23), H1 2018

Products under Development by Companies, H1 2018 (Contd..24), H1 2018

Products under Development by Companies, H1 2018 (Contd..25), H1 2018

Products under Development by Companies, H1 2018 (Contd..26), H1 2018

Products under Development by Companies, H1 2018 (Contd..27), H1 2018

Products under Development by Companies, H1 2018 (Contd..28), H1 2018

Products under Development by Companies, H1 2018 (Contd..29), H1 2018

Products under Development by Companies, H1 2018 (Contd..30), H1 2018

Products under Development by Companies, H1 2018 (Contd..31), H1 2018

Products under Development by Companies, H1 2018 (Contd..32), H1 2018

Products under Development by Companies, H1 2018 (Contd..33), H1 2018

Products under Development by Companies, H1 2018 (Contd..34), H1 2018

Products under Development by Companies, H1 2018 (Contd..35), H1 2018

Products under Development by Companies, H1 2018 (Contd..36), H1 2018

Products under Development by Universities/Institutes, H1 2018

Products under Development by Universities/Institutes, H1 2018 (Contd..1), H1 2018

Products under Development by Universities/Institutes, H1 2018 (Contd..2), H1 2018

Products under Development by Universities/Institutes, H1 2018 (Contd..3), H1 2018

Products under Development by Universities/Institutes, H1 2018 (Contd..4), H1 2018

Number of Products by Stage and Target, H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..1), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..2), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..3), H1 2018

Number of Products by Stage and Target, H1 2018 (Contd..4), H1 2018

List of Figures

Number of Products under Development for Pancreatic Cancer, H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Universities/Institutes, H1 2018

Number of Products by Top 10 Targets, H1 2018

Number of Products by Stage and Top 10 Targets, H1 2018

Number of Products by Top 10 Mechanism of Actions, H1 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018

Number of Products by Top 10 Routes of Administration, H1 2018

Number of Products by Stage and Top 10 Routes of Administration, H1 2018

Number of Products by Top 10 Molecule Types, H1 2018

Number of Products by Stage and Top 10 Molecule Types, H1 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3-V Biosciences Inc
  • 4P-Pharma SAS
  • 4SC AG
  • AB Science SA
  • AbbVie Inc
  • AbGenomics International Inc
  • Ability Pharmaceuticals SL
  • Aclaris Therapeutics Inc
  • Actuate Therapeutics Inc
  • Adamed Sp z oo
  • Aduro BioTech Inc
  • Advantagene Inc
  • AGV Discovery SAS
  • AIMM Therapeutics BV
  • Alissa Pharma
  • Alligator Bioscience AB
  • Allinky Biopharma
  • Altor BioScience Corp
  • Ambrx Inc
  • amcure GmbH
  • Amgen Inc
  • Amplia Therapeutics Pty Ltd
  • Anavex Life Sciences Corp
  • Andarix Pharmaceuticals Inc
  • ANP Technologies Inc
  • AntiCancer Inc
  • APEIRON Biologics AG
  • Apexigen Inc
  • Aphios Corp
  • Aposense Ltd
  • ARMO Biosciences Inc
  • ArQule Inc
  • Array BioPharma Inc
  • Asana BioSciences LLC
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Aurigene Discovery Technologies Ltd
  • AVEO Pharmaceuticals Inc
  • Axcentua Pharmaceuticals AB
  • Basilea Pharmaceutica Ltd
  • Bavarian Nordic A/S
  • Bayer AG
  • BeiGene Ltd
  • Bellicum Pharmaceuticals Inc
  • Berg LLC
  • BerGenBio ASA
  • Bexion Pharmaceuticals LLC
  • BeyondSpring Pharmaceuticals Inc
  • Bio-Path Holdings Inc
  • BioAtla LLC
  • BioLineRx Ltd
  • BioMoti Ltd
  • Biomunex Pharmaceuticals
  • Bionomics Ltd
  • BioNTech AG
  • Biothera Pharmaceutical Inc
  • Biouniversa srl
  • BLR Bio LLC
  • Boehringer Ingelheim GmbH
  • Boston Biomedical Inc
  • BriaCell Therapeutics Corp
  • Bristol-Myers Squibb Co
  • Calithera Biosciences Inc
  • Cancer Prevention Pharmaceuticals Inc
  • Cantargia AB
  • Cantex Pharmaceuticals Inc
  • CARsgen Therapeutics Ltd
  • CBT Pharmaceuticals Inc
  • CCRP Therapeutics GmbH
  • Celgene Corp
  • Celldex Therapeutics Inc
  • Cellectar Biosciences Inc
  • Celleron Therapeutics Ltd
  • Cellular Biomedicine Group Inc
  • Celprogen Inc
  • Celyad SA
  • Centrose LLC
  • Chem-Master International Inc
  • ChemoCentryx Inc
  • Chugai Pharmaceutical Co Ltd
  • Clovis Oncology Inc
  • COARE Biotechnology Inc
  • Codiak BioSciences Inc
  • Concordia International Corp
  • Corcept Therapeutics Inc
  • Cotinga Pharmaceuticals Inc
  • CPL Biologicals Pvt Ltd
  • CrystalGenomics Inc
  • CTI BioPharma Corp
  • Cyclacel Pharmaceuticals Inc
  • CytImmune Sciences Inc
  • Cytori Therapeutics Inc
  • CyTuVax BV
  • Daewoong Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • DEKK-TEC Inc
  • Denceptor Therapeutics Ltd
  • Diffusion Pharmaceuticals Inc
  • Eleison Pharmaceuticals LLC
  • Eli Lilly and Co
  • Endor Nanotechnologies SL
  • Ensol Biosciences Inc
  • Enterome Bioscience SA
  • Erytech Pharma SA
  • Esperance Pharmaceuticals Inc
  • Etubics Corp
  • Exelixis Inc
  • F. Hoffmann-La Roche Ltd
  • Faron Pharmaceuticals Oy
  • Felicitex Therapeutics Inc
  • FibroGen Inc
  • Formation Biologics Inc
  • Formosa Laboratories Inc
  • Forty Seven Inc
  • Fountain Biopharma Inc
  • Fujifilm Holdings Corporation
  • Fusion Antibodies Ltd
  • Galera Therapeutics Inc
  • GamaMabs Pharma SA
  • Geistlich Pharma AG
  • Genelux Corp
  • Genentech Inc
  • Genisphere LLC
  • Genmab A/S
  • Genoscience Pharma
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • GlycoMimetics Inc
  • Glycotope GmbH
  • Golden Biotechnology Corp
  • GW Pharmaceuticals Plc
  • Halozyme Therapeutics Inc
  • Heidelberg Pharma AG
  • Helix BioPharma Corp
  • Hemispherx Biopharma Inc
  • Horizon Pharma Plc
  • Icell Kealex Therapeutics LLC
  • Idera Pharmaceuticals Inc
  • Igenica Biotherapeutics Inc
  • Ignyta Inc
  • Immix BioPharma Inc
  • Immodulon Therapeutics Ltd
  • Immune System Key Ltd
  • Immunitor Inc
  • Immunomedics Inc
  • Immunotope Inc
  • Immunovo BV
  • Immupharma Plc
  • Incyte Corp
  • Inflection Biosciences Ltd
  • Innopharmax Inc
  • Innovation Pharmaceuticals Inc
  • Inovio Pharmaceuticals Inc
  • InteRNA Technologies BV
  • Intezyne Technologies Inc
  • Inventiva
  • InvivoGen Therapeutics
  • Io Therapeutics Inc
  • Iovance Biotherapeutics Inc
  • Ipsen SA
  • ISU ABXIS Co Ltd
  • Jasco Pharmaceuticals LLC
  • Jiangsu Hengrui Medicine Co Ltd
  • Johnson & Johnson
  • Juno Therapeutics Inc
  • Kalyra Pharmaceuticals Inc
  • Karcinolys SAS
  • Karyopharm Therapeutics Inc
  • Kazia Therapeutics Ltd
  • Keystone Nano Inc
  • Komipharm International Co Ltd
  • Kringle Pharma Inc
  • Kuhnil Pharmaceutical Co Ltd
  • Kura Oncology Inc
  • Kyowa Hakko Kirin Co Ltd
  • Lead Discovery Center GmbH
  • LIfT BioSciences Ltd
  • Lixte Biotechnology Holdings Inc
  • Loxo Oncology Inc
  • Lymphocyte Activation Technologies SA
  • MabVax Therapeutics Holdings Inc
  • Machavert Pharmaceuticals LLC
  • MacroGenics Inc
  • MaxiVAX SA
  • Meabco AS
  • Mebiopharm Co Ltd
  • MediaPharma SRL
  • Medicenna Therapeutics Corp
  • MediciNova Inc
  • MedImmune LLC
  • Merck & Co Inc
  • Merck KGaA
  • Merrimack Pharmaceuticals Inc
  • Merus NV
  • MetaMax Ltd
  • Millennium Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corp
  • Moderna Therapeutics Inc
  • Molecular Partners AG
  • Molecular Targeting Technologies Inc
  • Molecular Templates Inc
  • Moleculin Biotech LLC
  • Monopar Therapeutics Inc
  • Morphotek Inc
  • Mycenax Biotech Inc
  • NanoCarrier Co Ltd
  • NanoVector Inc
  • NantKwest Inc
  • Nascent Biotech Inc
  • Natco Pharma Ltd
  • NatureWise Biotech & Medicals Corp
  • NBE-Therapeutics AG
  • Nektar Therapeutics
  • Nerviano Medical Sciences Srl
  • NewLink Genetics Corp
  • NormOxys Inc
  • Northern Biologics Inc
  • Northwest Biotherapeutics Inc
  • Novartis AG
  • Noxxon Pharma AG
  • NuCana Plc
  • OBI Pharma Inc
  • Omeros Corp
  • Oncodesign SA
  • Oncology Research International Ltd
  • Oncolytics Biotech Inc
  • Oncomatryx Biopharma SL
  • OncoMed Pharmaceuticals Inc
  • OncoTherapy Science Inc
  • Oncovir Inc
  • Ono Pharmaceutical Co Ltd
  • Opsona Therapeutics Ltd
  • Optimum Therapeutics LLC
  • Oribase Pharma
  • Oryx GmbH & Co KG
  • OSE Immunotherapeutics
  • Oxford BioTherapeutics Ltd
  • Patrys Ltd
  • Pfizer Inc
  • Pharma Mar SA
  • PharmAbcine Inc
  • PharmaCyte Biotech Inc
  • Pharmedartis GmbH
  • Phenex Pharmaceuticals AG
  • Phoenix Biotechnology Inc
  • Plexxikon Inc
  • Polaris Pharmaceuticals Inc
  • POP Biotechnologies Inc
  • Precision Biologics Inc
  • Prescient Therapeutics Ltd
  • Propanc Biopharma Inc
  • Provectus Biopharmaceuticals Inc
  • Purdue Pharma LP
  • Puretech Health plc
  • Quest PharmaTech Inc
  • Quimatryx SL
  • Rafael Pharmaceuticals Inc
  • RedHill Biopharma Ltd
  • Rexahn Pharmaceuticals Inc
  • Rhizen Pharmaceuticals SA
  • RS Research
  • Sagetis Biotech SL
  • Samumed LLC
  • Samyang Holdings Corp
  • Sanofi
  • Sareum Holdings Plc
  • SATT North SAS
  • Scancell Holdings Plc
  • Seattle Genetics Inc
  • Selecta Biosciences Inc
  • SELLAS Life Sciences Group Inc
  • Siamab Therapeutics Inc
  • Sichuan Kelun Pharmaceutical Co Ltd
  • Sierra Oncology Inc
  • SignalChem Lifesciences Corp
  • SignPath Pharma Inc
  • SilaGene Inc
  • Silenseed Ltd
  • Sillajen Biotherapeutics
  • Sino Biopharmaceutical Ltd
  • Soricimed Biopharma Inc
  • Spring Bank Pharmaceuticals Inc
  • Strongbridge Biopharma plc
  • Sumitomo Dainippon Pharma Co Ltd
  • Sun BioPharma Inc
  • Sun Pharma Advanced Research Company Ltd
  • Swedish Orphan Biovitrum AB
  • Symic Biomedical Inc
  • Symphogen A/S
  • SynCore Biotechnology Co Ltd
  • Syndax Pharmaceuticals Inc
  • Synergys Biotherapeutics Inc
  • Synovo GmbH
  • Taiho Pharmaceutical Co Ltd
  • Takara Bio Inc
  • Takeda Pharmaceutical Co Ltd
  • Takis Srl
  • Targovax ASA
  • Tarveda Therapeutics Inc
  • TCR2 Therapeutics Inc
  • tella Inc
  • Tesaro Inc
  • Tiziana Life Sciences Plc
  • Tocagen Inc
  • Transcriptogen Ltd
  • Transgene SA
  • Trovagene Inc
  • Tyg Oncology Ltd
  • Tyme Technologies Inc
  • Tyrogenex Inc
  • UbiVac LLC
  • ValiRx Plc
  • VasGene Therapeutics Inc
  • Vault Pharma Inc
  • Vaxeal Holding SA
  • Vaximm AG
  • Vaxon Biotech
  • VCN Biosciences SL
  • Vect-Horus SAS
  • Verastem Inc
  • VG Life Sciences Inc
  • Vicus Therapeutics LLC
  • Viralytics Ltd
  • Virobay Inc
  • ViroStatics srl
  • XBiotech Inc
  • XuanZhu Pharma Co Ltd
  • Zeria Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll